Calcimar side effects, by duration, gender and age (a phase IV clinical study of FDA data)

Summary:

Side effects are reported by people who take Calcimar (calcitonin, salmon). Common side effects include arthralgia among females and abdominal distension among males.

The phase IV clinical study is created by eHealthMe based on 38 reports from the FDA, and is updated regularly.

What is Calcimar?

Calcimar has active ingredients of calcitonin, salmon. eHealthMe is studying from 42 Calcimar users. Check the latest studies of Calcimar.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

38 people who take Calcimar and have side effects are studied.

Calcimar side effects.

What are the common side effects of Calcimar, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Bone mass decreased
  4. Chills (felling of cold)
  5. Flushing (the warm, red condition of human skin)
  6. Oesophageal pain
  7. Osteonecrosis of jaw (death of bone of jaw)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

male:

  1. Abdominal distension
  2. Chest pain
  3. Death
  4. Pain

What are the common side effects of Calcimar, by age (0-1 to 60+) *:

0-1:

n/a

2-9:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

10-19:

n/a

20-29:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

30-39:

n/a

40-49:

  1. Abdominal distension
  2. Pain

50-59:

  1. Arthralgia (joint pain)
  2. Osteonecrosis of jaw (death of bone of jaw)

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Chest pain
  3. Death
  4. Dyspepsia (indigestion)
  5. Flushing (the warm, red condition of human skin)
  6. Oesophageal pain
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Abdominal pain
  9. Abnormal dreams
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

* Approximation only. Some reports may have incomplete information.

Do you take Calcimar?

- Personalize this study to your gender and age
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



How the study uses the data?

The study is based on calcitonin, salmon (the active ingredients of Calcimar) and Calcimar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies are listed below in case you need more information:

Alternative drugs to, pros and cons of Calcimar:

All Calcimar side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: